Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03245151
Title Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eisai Inc.
Indications

rhabdomyosarcoma

Advanced Solid Tumor

high grade glioma

Ewing sarcoma

Therapies

Everolimus + Lenvatinib

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.